Letter: the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 score
Antongiulio Faggiano(European Neuroendocrine Tumor Society), Annamaria Colao(European Gravitational Observatory), Salvatore Tafuto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Gaetano De Rosa(University of Naples Federico II), Elia Guadagno(Federico II University Hospital), Lorenzo Tozzi(Casa Sollievo della Sofferenza), Silvana Leo, Roberta Siciliano(University of Naples Federico II), Claudia Battista(Casa Sollievo della Sofferenza), Carmela Mocerino(Ospedale Antonio Cardarelli), Gabriella Palmieri(Regione Campania), V. Damiano(University of Naples Federico II), A Mauro(Ospedale Vito Fazzi), Fabiana Tatangelo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Anna Chiara Carratù(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Ferdinando Riccardi(Ospedale Antonio Cardarelli)
Cited by 1
Related Papers
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
|Endocrine Reviews|2004|1.3k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Persistence of Increased Cardiovascular Risk in Patients with Cushing’s Disease after Five Years of Successful Cure
|The Journal of Clinical Endocrinology & Metabolism|1999|417
Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing’s Disease during Active Disease and 1 Year after Disease Remission
|The Journal of Clinical Endocrinology & Metabolism|2003|355
The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
|The Journal of Clinical Endocrinology & Metabolism|2008|326